Search - tctmd.com

Displaying 901 - 920 of 991

Sort: Relevancy | Date

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

March 08, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

March 08, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

March 06, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

March 05, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

February 20, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presentation TCT 2012

Multicenter Clinical Trial with Everolimus-Eluting stent for the treatment of Bare-Metal in-stent restenosis. Immediate and long-term clinical and angiographic outcome

Presenter: Didier Carri?, Nicolas Delarche, Christophe Piot, Jacques Berland, Nicolas Meneveau, Laurent Benello, Antoine Py, Emmanuel Teiger, Laurent Leborgne, Gilles Bayet, Olivier Wittenberg

January 03, 2012

Are Results from an All-Comers Registry Comparable with the Results from an All-Comers Randomized Clinical Trial? Insights from 12-Month Results of the e-BioMatrix PMS Registry.

Presentation TCT 2012

Are Results from an All-Comers Registry Comparable with the Results from an All-Comers Randomized Clinical Trial? Insights from 12-Month Results of the e-BioMatrix PMS Registry.

Presenter: Philip Urban, Imad Al-Haddad, Jean Jacques Berland, Franz Eberli, Magdi El-Omar, Jean-Jacques Goy, David Hildick-Smith, David G. Iosseliani, Franz-Xaver Kleber, Keith Oldroyd, Giovanni B. Pedrazzini, Marco Roffi, Mariano Vald?s, Stephan Windecker

January 03, 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presentation TCT 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presenter: Klaus Bonaventura, Steffen Sonntag, Franz Xaver Kleber

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

November 30, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

November 28, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.